Doseology Sciences Inc. (CSE:MOOD)

Market Cap	2.74M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	7.84M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,200
Average Volume	2,427
Open	0.3850
Previous Close	0.2550
Day's Range	0.3500 - 0.3900
52-Week Range	0.0850 - 4.0000
Beta	-3.71
RSI	46.04
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc....

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD